Home Community MRI MRI discriminates new myocardial infarction from old infarct scar

MRI discriminates new myocardial infarction from old infarct scar

Communities

MRI using a combination of intravascular and extracellular contrast media can distinguish between acute myocardial infarction (MI) and chronic infarctions or scars.

NEW YORK (Reuters Health) - MRI using a combination of intravascular and extracellular contrast media can distinguish between acute myocardial infarction (MI) and chronic infarctions or scars, according to a report in the November 21st issue of the Journal of the American College of Cardiology.

Standard extracellular gadolinium (Gd)-chelates contrast enhancement cannot distinguish acute from chronic MI, the authors explain, but intravascular Gd-chelates may produce delayed contrast enhancement of acute but not old MI.

Dr. Maythem Saeed from the University of California, San Francisco, and colleagues examined the potential of intravascular Gd-chelates in discriminating acute from chronic MI in an animal model of 3-day-old and 8-week-old MI.

All acutely infarcted hearts showed delayed enhancement after administration of intravascular and extracellular Gd-chelates, the authors report. In contrast, intravascular Gd-chelate failed to enhance chronic infarctions.

Neither intravascular nor extracellular administration of Gd-chelate caused significant changes in blood pressure or arterial oxygen saturation in either the acute or chronic infarction setting, the researchers note.

"The capability of distinguishing acute MIs from scar tissue by intravascular Gd-chelate might be useful for excluding: 1) a new acute infarction in the clinical setting of known prior infarction or in the presence of ischemic cardiomyopathy, and 2) intraoperative or postoperative infarction in a patient with known prior infarction after revascularization," the investigators suggest.

"If there is no delayed enhancement after administration of intravascular Gd-chelates, it is not an acute infarction," the authors conclude. "Standard extracellular agents would also be preferable for discriminating nonviable from stunning and hibernating myocardium in cases of ischemic cardiomyopathy."

J Am Coll Cardiol 2006;48:1961-1968.
Trackback(0)
Comments (0)Add Comment

Write comment
smaller | bigger

busy
 

Related Articles

MRI Products

MRI Companies

MRI Join Group

Description: This group is for professionals involved in the MRI sector. Keep up-to-date with news, informed discussion and network with thought leaders.
Created: August 25, 2009, 8:54 pm
Owner: Devisree

Latest News

March 20, 2010, 12:02 pm By Deepa iCAD: Prostate & Breast MRI Imaging Technologies iCAD Takes Leadership Position in Meeting the Need for Accredited Educational Initiatives on Prostat...
March 19, 2010, 8:48 am By Deepa Medtronic Announces Advisa DR MRI SureScan Pacemaker Medtronic, Inc. announced the commercial availability of the Advisa DR MRI™ SureScan™ pacemaker in s...
March 17, 2010, 11:37 am By Deepa MRI-guided Ablation for Prostate Cancer Recurrences In prostate cancer patients following radical prostatectomy, magnetic resonance-guided ablation usin...
March 17, 2010, 8:59 am By Deepa STRMC Highlights Advantages of New MRI South Texas Regional Medical Center (STRMC) has announced that patients and physicians in the commun...
March 16, 2010, 11:54 am By Deepa MRI to Decide Heart Transplantation, LVAD Therapy AGH doctors tout potential of MRI as predictor of which heart failure patients will benefit most fro...
Discussions in MRI

Paul Keough
November 2, 2009, 1:44 pm ASTRO Sun Nov 1st: Integrating New and Emerging Modalities into Radiation Therapy Daivd Kirsh, MD, PhD, gave an excellent presentation, comment on your thoughts on these topics he ra...

Paul Keough
October 22, 2009, 12:47 pm buzz arounf er MRI? What are you seeing as patients, doctors, providers as far as testimonials around the use of er MRI?...
Comments in MRI
No Comments added yet.
Members
View all